Verify your purchase with our team of experts!
Product Details
AR-Encap® is a comprehensive joint support. It is formulated with Bromelain, Meriva® (curcumin phytosome), and Boswellia to help support the body's normal inflammatory response. Bromelain helps promote healing after trauma, and glucosamine and MSM provide proven joint support. It helps maintain healthy joint mobility and it can provide relief from occasional aches and soreness.
Suggested Use
Take 4 capsules one to two times daily or as recommended by a health-care practitioner.
Ingredients
Four Capsules Contain:
Medicinal Ingredients: - Chloride (from Glucosamine Sulfate Potassium Chloride complex) 87 mg - Potassium (from Glucosamine Sulfate Potassium Chloride complex) 98 mg - Methyl Sulfonyl Methane (MSM) 850 mg - Glucosamine Sulfate (as Glucosamine Sulfate Potassium Chloride complex) 750 mg - Indian Frankincense extract (gum) (Boswellia serrata) 350 mg - Curcumin Phytosome* (Curcuma longa extract (root) / Phosphatidylcholine complex) 250 mg - Bromelain** 200 mg
Other Ingredients: Hypromellose (derived from cellulose) capsule, Leucine, Silicon Dioxide.
This product uses Indena S.p.A.'s curcumin phytosome (Meriva®). Meriva is a registered trademark of Indena S.p.A.
Bromelain is derived from the pineapple plant (Ananas comosus). Boswellia standardized to Beta Boswellic Acids 20%.
Contains ingredients derived from shellfish (glucosamine sulfate = crab and/or shrimp) and soy (phytosome).
Cautions
This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients.
AR-Encap contains glucosamine derived from shellfish.
AR-Encap contains curcumin phytosome, a plant extract complexed with phosphatidylcholine, which is derived from soy. Phosphatidylcholine contains no soy protein. There are no other soy-based ingredients in AR-Encap.
If pregnant, consult your health-care practitioner before using this product.
Curcumin has been shown to reduce the therapeutic efficacy of cyclophosphamide (Cytoxan) in animal studies. In vitro research revealed that curcumin decreased camptothecin-induced death of cultured breast cancer cells. Curcumin might also interfere with the absorption and efficacy of the chemotherapy drug irinotecan, used to treat colon cancer. The concurrent use of curcumin with these agents should be avoided.